Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Nautilus Biotechnology, Inc./ EFFECT

Notice of Effectiveness · EFFECT

Nautilus Biotechnology, Inc.

NAUTNASDAQEQUITYCurrent

Notice of Effectiveness

Filed Sep 18, 2026Accepted Sep 21, 2026, 12:15 AM EDTFiling CIK 1808805Accession 9999999995-26-003012
View company →Permanent SEC source ↗
Share

Structured filing — EFFECT

primary_doc.xml

Open full document ↗

Notice details

Submission type
EFFECT
Act
33

Effectiveness

Effective date
2026-09-18
Effective time (as filed)
16:00:00
Form
S-3

Registrant 1

Registrant
Nautilus Biotechnology, Inc.
Registrant CIK
0001808805
File number
333-298884

Company context

Current securities

NAUTNASDAQ · EQUITY · Current
Historical securities (1)
ARYANASDAQ · EQUITY · Historical · closed Jun 9, 2021

Recent company filings

  1. SCHEDULE 13D/A - filed by PERCEPTIVE ADVISORS LLC regarding Nautilus Biotechnology, Inc.Nov 3, 2026
  2. 10-Q filingOct 27, 2026
  3. Results of Operations and Financial ConditionOct 27, 2026
  4. 424B5 filingSep 18, 2026
  5. SCHEDULE 13D/A - filed by AH Bio Fund II, L.P. regarding Nautilus Biotechnology, Inc.Sep 11, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.